Showing results (151-160 of 191) with videos related to

Sort By:
Pageof 20
Plos One|June 22, 2017
Hemodynamic and metabolic characteristics associated with development of a right ventricular outflow tract pressure gradient during upright exerciseAnnelieke C M J van Riel, David M Systrom, Rudolf K F Oliveira, et al.
BMJ Open Respiratory Research|March 22, 2024
Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE studyJason Weatherald, Steven D Nathan, Karim El-Kersh, et al.
Pulmonary Circulation|December 24, 2015
Protocol for exercise hemodynamic assessment: performing an invasive cardiopulmonary exercise test in clinical practiceNatalia C Berry, Agarwal Manyoo, William M Oldham, et al.
Respiratory Research|December 2, 2022
Perfusion imaging heterogeneity during NO inhalation distinguishes pulmonary arterial hypertension (PAH) from healthy subjects and has potential as an imaging biomarkerTilo Winkler, Puja Kohli, Vanessa J Kelly, et al.
ERJ Open Research|September 24, 2025
Detection of pulmonary hypertension in idiopathic pulmonary fibrosis using random forest models and automated measures of central computed tomography structuresToru Shirahata, Pietro Nardelli, Sirus Jesudasen, et al.
Circulation|January 10, 2014
Dantrolene improves survival after ventricular fibrillation by mitigating impaired calcium handling in animal modelsNima Zamiri, Stéphane Massé, Andrew Ramadeen, et al.
The European Respiratory Journal|February 20, 2025
A Long-Term Follow-Up Study of Sotatercept for Treatment of Pulmonary Arterial Hypertension: Interim Results of SOTERIAIoana R Preston, David Badesch, Hossein-Ardeschir Ghofrani, et al.
Pulmonary Circulation|November 15, 2019
Long-term results of the DelIVery for Pulmonary Arterial Hypertension trialMardi Gomberg-Maitland, Robert C Bourge, Shelley M Shapiro, et al.
Chest|July 12, 2016
Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH TrialRobert C Bourge, Aaron B Waxman, Mardi Gomberg-Maitland, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 24, 2016
Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertensionReza Aghamohammadzadeh, Ying-Yi Zhang, Thomas E Stephens, et al.
Pageof 20